Abciximab provides cost-effective survival advantage in high-volume interventional practice
Dean J. Kereiakes,
Robert L. Obenchain,
Beth Barber,
Andrew Smith,
Mark McDonald,
Thomas M. Broderick,
John Paul Runyon,
Thomas Shimshak,
John F. Schneider,
Charles R. Hattemer,
American Heart Journal · 2000 · 26 citations · 26 references